OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
18.05
+0.23 (1.29%)
Mar 6, 2026, 4:00 PM EST - Market closed
OrthoPediatrics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for OrthoPediatrics stock have an average target of 24.67, with a low estimate of 20 and a high estimate of 34. The average target predicts an increase of 36.68% from the current stock price of 18.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OrthoPediatrics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | +10.80% | Mar 2, 2026 |
| Needham | Needham | Strong Buy Maintains $26 → $30 | Strong Buy | Maintains | $26 → $30 | +66.20% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +32.96% | Feb 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +27.42% | Jan 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +32.96% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
269.60M
from 236.35M
Increased by 14.07%
Revenue Next Year
301.55M
from 269.60M
Increased by 11.85%
EPS This Year
-1.16
from -1.69
EPS Next Year
-0.77
from -1.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 278.3M | 313.7M | |||
| Avg | 269.6M | 301.6M | |||
| Low | 258.7M | 288.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.7% | 16.4% | |||
| Avg | 14.1% | 11.9% | |||
| Low | 9.5% | 7.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.04 | -0.32 | |||
| Avg | -1.16 | -0.77 | |||
| Low | -1.48 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.